Angela Dispenzieri

TL;DR: In this article, the authors identified 63 patients with 1q22 gain at diagnosis who acquired it during follow up and compared them to 63 control patients who did not acquire 1q 22 gain with similar follow up.

TL;DR: Clinical efficacy was seen in all diseases tested with partial responses seen in NHL and HL as well as a minor response in a patient with refractory myeloma, who had previously failed single agent RAD001.

TL;DR: In patients presenting with low-risk MGUS and normal hemoglobin, calcium, and renal function, the risk of missing a diagnosis of SMM and MM by omitting BM is <1%.

TL;DR: This study aimed to investigate the frequency of ATTR in amyloid‐positive tendon/synovium, urinary bladder, and prostate biopsies, sites for which prior biopsy specimens might exist for patients suspected of having cardiac amyloidsosis, and determine the amyloidal type concordance rate with other anatomic sites and provide clinical data regarding subsequent development of cardiac ameloidosis.

TL;DR: This manuscript attempts to unravel the relationship of AL LCs and the PCs that produce them in the context of AL PC susceptibility to proteasome inhibitors and the role autophagy may play in that susceptibility.